Macular Pigment Optical Density in First Degree Relatives of Age-Related Macular Degeneration Patients

References

• Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2(2):e106–e116. doi: 10.1016/S2214-109X(13)70145-1.
   PubMed Web of Science ®Google Scholar
• Williams RA, Brody BL, Thomas RG, Kaplan RM, Brown SI. The psychosocial impact of macular degeneration. Arch Ophthalmol. 1998;116(4):514–520. doi: 10.1001/archopht.116.4.514.
   PubMed Web of Science ®Google Scholar
• Allikmets R, Shroyer NF, Singh N, Seddon JM, Lewis RA, Bernstein PS, Peiffer A, Zabriskie NA, Li Y, Hutchinson A, et al. Mutation of the Stargardt disease gene (ABCR) in age-related macular degeneration. Science. 1997;277(5333):1805–1807. doi: 10.1126/science.277.5333.1805.
   PubMed Web of Science ®Google Scholar
• Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol. 1993;111(4):514–518. doi: 10.1001/archopht.1993.01090040106042.
   PubMedGoogle Scholar
• Taylor HR, Muñoz B, West S, Bressler NM, Bressler SB, Rosenthal FS. Visible light and risk of age-related macular degeneration. Trans Am Ophthalmol Soc. 1990;88:163–173.
   PubMedGoogle Scholar
• Friedman E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124(5):677–682. doi: 10.1016/s0002-9394(14)70906-7.
   PubMed Web of Science ®Google Scholar
• Cai J, Nelson KC, Wu M, Sternberg P, Jr., Jones DP. Oxidative damage and protection of the RPE. Prog Retin Eye Res. 2000;19(2):205–221. doi: 10.1016/s1350-9462(99)00009-9.
   PubMed Web of Science ®Google Scholar
• Beatty S, Murray IJ, Henson DB, Carden D, Koh H, Boulton ME. Macular pigment and risk for age-related macular degeneration in subjects from a Northern European population. Invest Ophthalmol Vis Sci. 2001;42(2):439–446.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Ajani UA, Mitchell BD. Familial aggregation of age-related maculopathy. Am J Ophthalmol. 1997;123(2):199–206. doi: 10.1016/s0002-9394(14)71036-0.
   PubMed Web of Science ®Google Scholar
• Colijn JM, Meester-Smoor M, Verzijden T, de Breuk A, Silva R, Merle BMJ, Cougnard-Grégoire A, Hoyng CB, Fauser S, Coolen A, et al. Genetic risk, lifestyle, and age-related macular degeneration in Europe: the EYE-RISK Consortium. Ophthalmology. 2021;128(7):1039–1049. doi: 10.1016/j.ophtha.2020.11.024.
   PubMed Web of Science ®Google Scholar
• Chakravarthy U, McKay GJ, de Jong PTVM, Rahu M, Seland J, Soubrane G, Tomazzoli L, Topouzis F, Vingerling JR, Vioque J, et al. ARMS2 increases the risk of early and late age-related macular degeneration in the European Eye Study. Ophthalmology. 2013;120(2):342–348. doi: 10.1016/j.ophtha.2012.08.004.
   PubMed Web of Science ®Google Scholar
• Contreras AV, Zenteno JC, Fernández-López JC, Rodríguez-Corona U, Falfán-Valencia R, Sebastian L, Morales F, Ochoa-Contreras D, Carnevale A, Silva-Zolezzi I. CFH haplotypes and ARMS2, C2, C3, and CFB alleles show association with susceptibility to age-related macular degeneration in Mexicans. Mol Vis. 2014;20:105–116.
   PubMed Web of Science ®Google Scholar
• Fritsche LG, Igl W, Bailey JNC, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48(2):134–143. doi: 10.1038/ng.3448.
   PubMed Web of Science ®Google Scholar
• Lambert NG, ElShelmani H, Singh MK, Mansergh FC, Wride MA, Padilla M, Keegan D, Hogg RE, Ambati BK. Risk factors and biomarkers of age-related macular degeneration. Prog Retin Eye Res. 2016;54:64–102. doi: 10.1016/j.preteyeres.2016.04.003.
   PubMed Web of Science ®Google Scholar
• Shahid H, Khan JC, Cipriani V, Sepp T, Matharu BK, Bunce C, Harding SP, Clayton DG, Moore AT, Yates JR, et al. Age-related macular degeneration: the importance of family history as a risk factor. Br J Ophthalmol. 2012;96(3):427–431. doi: 10.1136/bjophthalmol-2011-300193.
   PubMed Web of Science ®Google Scholar
• Seddon JM, Cote J, Page WF, Aggen SH, Neale MC. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. Arch Ophthalmol. 2005;123(3):321–327. doi: 10.1001/archopht.123.3.321.
   PubMed Web of Science ®Google Scholar
• Eisenhauer B, Natoli S, Liew G, Flood VM. Lutein and zeaxanthin-food sources, bioavailability and dietary variety in age-related macular degeneration protection. Nutrients. 2017;9(2):1–14. doi: 10.3390/nu9020120.
   Web of Science ®Google Scholar
• Sae-Lao W, Wunjuntuk K, Techakriengkrai T, Sirichakwal PP. Consumption of lutein and zeaxanthin and its relation to the level of macular pigment optical density in Thai subjects. J Nutr Metab. 2022;2022:6321778. doi: 10.1155/2022/6321778.
   PubMed Web of Science ®Google Scholar
• Johnson EJ. Role of lutein and zeaxanthin in visual and cognitive function throughout the lifespan. Nutr Rev. 2014;72(9):605–612. doi: 10.1111/nure.12133.
   PubMed Web of Science ®Google Scholar
• Weigert G, Kaya S, Pemp B, Sacu S, Lasta M, Werkmeister RM, Dragostinoff N, Simader C, Garhöfer G, Schmidt-Erfurth U, et al. Effects of lutein supplementation on macular pigment optical density and visual acuity in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2011;52(11):8174–8178. doi: 10.1167/iovs.11-7522.
   PubMed Web of Science ®Google Scholar
• Hammond BR, Jr., Johnson EJ, Russell RM, Krinsky NI, Yeum KJ, Edwards RB, Snodderly DM. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38(9):1795–1801.
   PubMed Web of Science ®Google Scholar
• Liew SH, Gilbert CE, Spector TD, Mellerio J, Marshall J, van Kuijk FJ, Beatty S, Fitzke F, Hammond CJ. Heritability of macular pigment: a twin study. Invest Ophthalmol Vis Sci. 2005;46(12):4430–4436. doi: 10.1167/iovs.05-0519.
   PubMed Web of Science ®Google Scholar
• Liu R, Hannon BA, Robinson KN, Raine LB, Hammond BR, Renzi-Hammond LM, Cohen NJ, Kramer AF, Hillman CH, Teran-Garcia M, et al. Single nucleotide polymorphisms in CD36 are associated with macular pigment among children. J Nutr. 2021;151(9):2533–2540. doi: 10.1093/jn/nxab153.
   PubMedGoogle Scholar
• Hammond BR, Jr, Fuld K, Curran-Celentano J. Macular pigment density in monozygotic twins. Invest Ophthalmol Vis Sci. 1995;36(12):2531–2541.
   PubMed Web of Science ®Google Scholar
• Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density. Appended with translations from the work of Max Schultze and Ewald Hering. Vision Res. 1987;27(2):257–268. doi: 10.1016/0042-6989(87)90188-x.
   PubMed Web of Science ®Google Scholar
• de Kinkelder R, van der Veen RL, Verbaak FD, Faber DJ, van Leeuwen TG, Berendschot TT. Macular pigment optical density measurements: evaluation of a device using heterochromatic flicker photometry. Eye. 2011;25(1):105–112. doi: 10.1038/eye.2010.164.
   PubMed Web of Science ®Google Scholar
• Bartlett H, Howells O, Eperjesi F. The role of macular pigment assessment in clinical practice: a review. Clin Exp Optom. 2010;93(5):300–308. doi: 10.1111/j.1444-0938.2010.00499.x.
   PubMed Web of Science ®Google Scholar
• Brown GC, Brown MM, Sharma S, Stein JD, Roth Z, Campanella J, Beauchamp GR. The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc. 2005;103:173–184.
   PubMedGoogle Scholar
• Nolan JM, Stack J, O' Donovan O, Loane E, Beatty S. Risk factors for age-related maculopathy are associated with a relative lack of macular pigment. Exp Eye Res. 2007;84(1):61–74. doi: 10.1016/j.exer.2006.08.016.
   PubMed Web of Science ®Google Scholar
• Howells O, Eperjesi F, Bartlett H. Measuring macular pigment optical density in vivo: a review of techniques. Graefes Arch Clin Exp Ophthalmol. 2011;249(3):315–347. doi: 10.1007/s00417-010-1577-5.
   PubMed Web of Science ®Google Scholar
• Howells O, Eperjesi F, Bartlett H. Improving the repeatability of heterochromatic flicker photometry for measurement of macular pigment optical density. Graefes Arch Clin Exp Ophthalmol. 2013;251(3):871–880. doi: 10.1007/s00417-012-2127-0.
   PubMed Web of Science ®Google Scholar
• Davey PG, Alvarez SD, Lee JY. Macular pigment optical density: repeatability, intereye correlation, and effect of ocular dominance. Clin Ophthalmol. 2016;10:1671–1678. doi: 10.2147/OPTH.S111708.
   PubMedGoogle Scholar
• Davey PG, Rosen RB, Gierhart DL. Macular pigment reflectometry: developing clinical protocols, comparison with heterochromatic flicker photometry and individual carotenoid levels. Nutrients. 2021;13(8):1–17. doi: 10.3390/nu13082553.
   Web of Science ®Google Scholar
• Wu J, Seregard S, Algvere PV. Photochemical damage of the retina. Surv Ophthalmol. 2006;51(5):461–481. doi: 10.1016/j.survophthal.2006.06.009.
   PubMed Web of Science ®Google Scholar
• Algvere PV, Marshall J, Seregard S. Age-related maculopathy and the impact of blue light hazard. Acta Ophthalmol Scand. 2006;84(1):4–15. doi: 10.1111/j.1600-0420.2005.00627.x.
   PubMedGoogle Scholar
• Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res. 2006;82(5):828–839. doi: 10.1016/j.exer.2005.10.004.
   PubMed Web of Science ®Google Scholar
• Beatty S, Koh H-H, Phil M, Henson D, Boulton M. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45(2):115–134. doi: 10.1016/s0039-6257(00)00140-5.
   PubMed Web of Science ®Google Scholar
• Berendschot TT, van Norren D. Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci. 2006;47(2):709–714. doi: 10.1167/iovs.05-0663.
   PubMed Web of Science ®Google Scholar
• Delori FC, Goger DG, Keilhauer C, Salvetti P, Staurenghi G. Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J Opt Soc Am A Opt Image Sci Vis. 2006;23(3):521–538. doi: 10.1364/josaa.23.000521.
   PubMed Web of Science ®Google Scholar
• Trieschmann M, Spital G, Lommatzsch A, van Kuijk E, Fitzke F, Bird AC, Pauleikhoff D. Macular pigment: quantitative analysis on autofluorescence images. Graefes Arch Clin Exp Ophthalmol. 2003;241(12):1006–1012. doi: 10.1007/s00417-003-0796-4.
   PubMed Web of Science ®Google Scholar
• Ciulla TA, Hammond BR. Jr. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol. 2004;138(4):582–587. doi: 10.1016/j.ajo.2004.05.057.
   PubMed Web of Science ®Google Scholar
• LaRowe TL, Mares JA, Snodderly DM, Klein ML, Wooten BR, Chappell R, CAREDS Macular Pigment Study Group. Macular pigment density and age-related maculopathy in the carotenoids in age-related eye disease study. An ancillary study of the women’s health initiative. Ophthalmology. 2008;115(5):876–883.e1. doi: 10.1016/j.ophtha.2007.06.015.
   PubMed Web of Science ®Google Scholar
• van der Veen RL, Berendschot TT, Makridaki M, Hendrikse F, Carden D, Murray IJ. Correspondence between retinal reflectometry and a flicker-based technique in the measurement of macular pigment spatial profiles. J Biomed Opt. 2009;14(6):064046. doi: 10.1117/1.3275481.
   PubMed Web of Science ®Google Scholar
• van der Veen RL, Berendschot TT, Hendrikse F, Carden D, Makridaki M, Murray IJ. A new desktop instrument for measuring macular pigment optical density based on a novel technique for setting flicker thresholds. Ophthalmic Physiol Opt. 2009;29(2):127–137. doi: 10.1111/j.1475-1313.2008.00618.x.
   PubMed Web of Science ®Google Scholar
• Stringham JM, Hammond BR, Nolan JM, Wooten BR, Mammen A, Smollon W, Snodderly DM. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res. 2008;87(5):445–453. doi: 10.1016/j.exer.2008.08.005.
   PubMed Web of Science ®Google Scholar
• Bartlett H, Acton J, Eperjesi F. Clinical evaluation of the MacuScope macular pigment densitometer. Br J Ophthalmol. 2010;94(3):328–331. doi: 10.1136/bjo.2009.167213.
   PubMed Web of Science ®Google Scholar
• Tang CY, Yip HS, Poon MY, Yau WL, Yap MK. Macular pigment optical density in young Chinese adults. Ophthalmic Physiol Opt. 2004;24(6):586–593. doi: 10.1111/j.1475-1313.2004.00242.x.
   PubMed Web of Science ®Google Scholar
• Saksens NT, Lechanteur YT, Verbakel SK, Groenewoud JM, Daha MR, Schick T, Fauser S, Boon CJ, Hoyng CB, den Hollander AI. Analysis of risk alleles and complement activation levels in familial and non-familial age-related macular degeneration. PLOS One. 2016;11(6):e0144367. doi: 10.1371/journal.pone.0144367.
   PubMed Web of Science ®Google Scholar
• Shughoury A, Sevgi DD, Ciulla TA. Molecular genetic mechanisms in age-related macular degeneration. Genes. 2022;13(7):1–28. doi: 10.3390/genes13071233.
   Web of Science ®Google Scholar
• Leung IY. Macular pigment: new clinical methods of detection and the role of carotenoids in age-related macular degeneration. Optometry. 2008;79(5):266–272. doi: 10.1016/j.optm.2007.03.017.
   PubMedGoogle Scholar
• Kijlstra A, Tian Y, Kelly ER, Berendschot TT. Lutein: more than just a filter for blue light. Prog Retin Eye Res. 2012;31(4):303–315. doi: 10.1016/j.preteyeres.2012.03.002.
   PubMed Web of Science ®Google Scholar
• Age-Related Eye Disease Study 2 Research Group. Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 2013;309(19):2005–2015.
   PubMed Web of Science ®Google Scholar
• Nusinowitz S, Wang Y, Kim P, Habib S, Baron R, Conley Y, Gorin M. Retinal structure in pre-clinical age-related macular degeneration. Curr Eye Res. 2018;43(3):376–382. doi: 10.1080/02713683.2017.1401646.
   PubMed Web of Science ®Google Scholar
• Wood A, Binns A, Margrain T, Drexler W, Považay B, Esmaeelpour M, Sheen N. Retinal and choroidal thickness in early age-related macular degeneration. Am J Ophthalmol. 2011;152(6):1030–1038.e2. doi: 10.1016/j.ajo.2011.05.021.
   PubMed Web of Science ®Google Scholar
• Manjunath V, Goren J, Fujimoto JG, Duker JS. Analysis of choroidal thickness in age-related macular degeneration using spectral-domain optical coherence tomography. Am J Ophthalmol. 2011;152(4):663–668. doi: 10.1016/j.ajo.2011.03.008.
   PubMed Web of Science ®Google Scholar
• Lee HK, Lim JW, Shin MC. Comparison of choroidal thickness in patients with diabetes by spectral-domain optical coherence tomography. Korean J Ophthalmol. 2013;27(6):433–439. doi: 10.3341/kjo.2013.27.6.433.
   PubMedGoogle Scholar
• Sigler EJ, Randolph JC. Comparison of macular choroidal thickness among patients older than age 65 with early atrophic age-related macular degeneration and normals. Invest Ophthalmol Vis Sci. 2013;54(9):6307–6313. doi: 10.1167/iovs.13-12653.
   PubMed Web of Science ®Google Scholar
• Lu L, Xu S, He F, Liu Y, Zhang Y, Wang J, Wang Z, Fan X. Assessment of choroidal microstructure and subfoveal thickness change in eyes with different stages of age-related macular degeneration. Medicine. 2016;95(10):e2967. doi: 10.1097/MD.0000000000002967.
   PubMed Web of Science ®Google Scholar
• Farazdaghi MK, Ebrahimi KB. Role of the choroid in age-related macular degeneration: a current review. J Ophthalmic Vis Res. 2019;14(1):78–87. doi: 10.4103/jovr.jovr_125_18.
   PubMed Web of Science ®Google Scholar